Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Classical hematology 1CNS 1

Conditions

Multiple Myeloma 16Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 10Lymphoma 9Leukemia 8Burkitt Lymphoma 8Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 6Hodgkin Disease 6Congenital Abnormalities 6Sarcoma 5Recurrence 5Neoplasms, Plasma Cell 5Lymphoma, B-Cell, Marginal Zone 5Leukemia, Lymphocytic, Chronic, B-Cell 5Hematologic Neoplasms 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Lymphoma, Mantle-Cell 4Lymphoma, Large B-Cell, Diffuse 4Central Nervous System Neoplasms 4Breast Neoplasms 4Wilms Tumor 3Retinoblastoma 3Neuroblastoma 3Neoplasm Metastasis 3Medulloblastoma 3Lymphoma, Large-Cell, Immunoblastic 3Leukemia, Myelomonocytic, Juvenile 3Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 3

Interventions

Rituximab 5Peripheral Blood Stem Cell Transplantation 3Lenalidomide 2Ipilimumab 2Etoposide 2Dasatinib 2Cyclophosphamide 2CTLA-4 Antigen 2tanespimycin 1sodium thiosulfate 1pegfilgrastim 1obatoclax 1ibrutinib 1fludarabine phosphate 1etoposide phosphate 1devimistat 1belinostat 1amuvatinib 1Vorinostat 1Vincristine 1Tacrolimus 1Sirolimus 1Razoxane 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Oxycodone 1Oxaliplatin 1Moxifloxacin 1Morphine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Intraocular Lymphoma × Granulocyte Colony-Stimulating Factor × Clear all
NCT00074165 2023-07-06

Treating Patients With Recurrent PCNSL With Carboplatin/BBBD and Adding Rituxan To The Treatment Regimen

OHSU Knight Cancer Institute

Phase 2 Terminated
17 enrolled 7 charts
CNSClassical hematologyLymphoid

Lymphoma, Thrombocytopenia, Central Nervous System Neoplasms, Intraocular Lymphoma, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡